基于 4 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Brynelsen Charles. Director active across 1 company, notably Envoy Medical, Inc.. Aggregated, 4 reports have been recorded. Split: 4 buys · 0 sell. Total volume traded: €410k. Activity tracked since 22 May 2025. The latest transaction was filed on 12 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
BRYNELSEN CHARLES is a declarant linked to Envoy Medical, Inc., where he is Director. Across 4 filings in total, the 4 sampled filings between 2025-05-27 and 2026-02-17 show acquisitions, with buy volume of EUR 409603 and no reported sales.